Trials / Unknown
UnknownNCT05275387
AQP-1 Polymorphism on Fluid Status in Hemodialysis Patients
the Effect of AQP-1 Polymorphism on Fluid Status of Hemodialysis Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
It is a cross sectional observational study. It is to investigate whether AQP-1 polymorphism has any impact on fluid status in hemodialysis patients. The long term stable HD patients in the current center will be enrolled to the study after informed consent. Blood samples will be collected for gene-typing. Fluid status including blood pressure, weekly UF and intra-dialysis body weight change will be collected through their clinical records.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | observational study, no intervention | observational study, no intervention |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2023-01-30
- Completion
- 2023-02-28
- First posted
- 2022-03-11
- Last updated
- 2022-11-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05275387. Inclusion in this directory is not an endorsement.